September 26th, 2022
Stilla at the 12th World Clinical Biomarkers & CDx Summit
Join us at the 12th World Clinical Biomarkers & CDx Summit in Boston this September 26-29th. Philippe Mourere, Stilla President & CEO, will present: Getting de-centralized testing into routine clinical oncology using high-performance genetic multiplexing with digital PCR on Thursday, September 29th at 2:55pm
